biologics treatment

Phase 3Biologic

TTaichung Veterans General Hospital

biologics treatment is one of 35 biologic programs targeting Psoriatic Arthritis. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Psoriatic ArthritisRecruiting

Psoriatic ArthritisPhase 3

Recruiting

Competition

Competitive Landscape

36 competitors in Psoriatic Arthritis

#DrugCompanyPhaseTrials

Otezla

Amgen

Approved

18 2

Trexall

Jazz Pharmaceuticals

Approved

13 3

Bimzelx

UCB

Approved

9 4

Taltz

Eli Lilly

Approved

8 5

Rinvoq

AbbVie

Approved

4 6

Mounjaro

Eli Lilly

Approved

3 7

Arava

Sanofi

Approved

2 8

Azulfidine

Pfizer

Approved

2 9

Ozempic

Novo Nordisk

Approved

1 10

Talzenna

Pfizer

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2028

Post-ApprovalRecruiting

Psoriatic Arthritis

NCT07149792

Clinical

Trials by Indication[1]

Psoriatic Arthritis1 trial

A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers

Recruiting·TTaichung Veterans General Hospital·Phase 4·NCT07149792·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for biologics treatment. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — biologics treatment compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for biologics treatment. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Taichung Veterans General Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 3[1]
Company: TTaichung Veterans General Hospital

biologics treatment

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2028

Trials by Indication[1]

Psoriatic Arthritis1 trial

References

Drug Info

Quick Facts

Related News